1,3,4,6,7,8-六氢-4,6,6,7,8,8-六甲基环戊[g]-2-苯并吡喃; 1,3,4,6,7,8-六氢-4,6,6,7,8,8-六甲基-环戊并[G]-2-苯并吡喃; 1,3,4,6,7,8-六氢-4,6,6,7,8,8-六甲基-环戊并[G]-2-苯并吡喃; 1,3,4,6,7,8-六氢-4,6,6,7,8,8,-季戊四醇(七)-2-苯并吡喃; 8-六氢-4; 佳乐麝香; 佳乐麝香; 六甲基茚满并吡喃; 8-六甲基环戊并[g]-2-苯并吡喃; 加乐麝香; 三环异色满麝香
Cyclopenta[g]-2-benzopyran, 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl-; ABBALIDE; Galoxolide; 7-acetyl-1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphthalene; 7-acetyl-1,1,3,4,4,6-hexamethyltetraline; EINECS 214-946-9; 5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl-ethanone; 7-acetyl-1,1,3,4,4,6-hexamethyl-tetrahydronaphthalene; 8-hexamethylcyclopenta[g]-2-benzopyran; MFCD00217003; 6-acetyl-1,1,2,4,4,7-hexamethyl-tetralin; Musk50; 4,6,6,7,8,8-Hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene; 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran; 8-Hexahydro-4; PEARLIDE PURE; Pearlide; Galaxolide; Indeno[5,6-c]pyran, 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl-; 6-acetyl-1,1,2,4,4,7-hexamethyl-1,2,3,4-tetrahydronaphthalene; HHCB; Venlafaxine; Cimalide 50; 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethyl-cyclopenta-gamma-2-benzopyran; _x005f ; 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride (1:1); 4,6,6,7,8,8-hexamethyl-1,3,4,6,7,8-hexahydrocyclopenta[g]isochromene; Galaxolide Abbalide; 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno(5,6-c)pyr
贮运及保管镀锡铁桶装。正常贮运比较安全。
1、 摩尔折射率:80.26 2、 摩尔体积(cm3/mol):273.2 3、 等张比容(90.2K):649.0 4、 表面张力(dyne/cm):31.8 5、 极化率(10-24cm3):31.81
1.疏水参数计算参考值(XlogP):4.8 2.氢键供体数量:0 3.氢键受体数量:1 4.可旋转化学键数量:0 5.互变异构体数量:无 6.拓扑分子极性表面积9.2 7.重原子数量:19 8.表面电荷:0 9.复杂度:357 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:2 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1
1.性状:无色黏稠液体。 2.沸点(ºC):304
PDF: 1222-05-5_ch
PDF: 1222-05-5_en